Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections
Stock Information for Inovio Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.